BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26054340)

  • 1. The importance of claudin-7 palmitoylation on membrane subdomain localization and metastasis-promoting activities.
    Heiler S; Mu W; Zöller M; Thuma F
    Cell Commun Signal; 2015 Jun; 13():29. PubMed ID: 26054340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylated claudin7 captured in glycolipid-enriched membrane microdomains promotes metastasis via associated transmembrane and cytosolic molecules.
    Thuma F; Heiler S; Schnölzer M; Zöller M
    Oncotarget; 2016 May; 7(21):30659-77. PubMed ID: 27120791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EpCAM-associated claudin-7 supports lymphatic spread and drug resistance in rat pancreatic cancer.
    Thuma F; Zöller M
    Int J Cancer; 2013 Aug; 133(4):855-66. PubMed ID: 23390083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
    Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
    Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cell adhesion molecule (EpCAM) regulates claudin dynamics and tight junctions.
    Wu CJ; Mannan P; Lu M; Udey MC
    J Biol Chem; 2013 Apr; 288(17):12253-68. PubMed ID: 23486470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-7 regulates EpCAM-mediated functions in tumor progression.
    Nübel T; Preobraschenski J; Tuncay H; Weiss T; Kuhn S; Ladwein M; Langbein L; Zöller M
    Mol Cancer Res; 2009 Mar; 7(3):285-99. PubMed ID: 19276185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
    Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
    Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7.
    Ladwein M; Pape UF; Schmidt DS; Schnölzer M; Fiedler S; Langbein L; Franke WW; Moldenhauer G; Zöller M
    Exp Cell Res; 2005 Oct; 309(2):345-57. PubMed ID: 16054130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins.
    Lei Z; Maeda T; Tamura A; Nakamura T; Yamazaki Y; Shiratori H; Yashiro K; Tsukita S; Hamada H
    Dev Biol; 2012 Nov; 371(2):136-45. PubMed ID: 22819673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Origin of Claudin7 in Early Tumor Endosomes Affects Exosome Assembly.
    Kyuno D; Bauer N; Schnölzer M; Provaznik J; Ryschich E; Hackert T; Zöller M
    Int J Biol Sci; 2019; 15(10):2224-2239. PubMed ID: 31592143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
    Kuhn S; Koch M; Nübel T; Ladwein M; Antolovic D; Klingbeil P; Hildebrand D; Moldenhauer G; Langbein L; Franke WW; Weitz J; Zöller M
    Mol Cancer Res; 2007 Jun; 5(6):553-67. PubMed ID: 17579117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions.
    Le Naour F; Zoller M
    Front Biosci; 2008 May; 13():5847-65. PubMed ID: 18508627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of serine phosphorylated claudin-7 on the epithelial barrier and the modulation by transient receptor potential vanilloid 4 in human colonic cells.
    Huang YY; Wang ZK; Li J; Bai SW; Shen B; Du J; Xia XM; Wang FY
    Biomed Pharmacother; 2018 Dec; 108():540-546. PubMed ID: 30243087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 variant isoforms associate with tetraspanins and EpCAM.
    Schmidt DS; Klingbeil P; Schnölzer M; Zöller M
    Exp Cell Res; 2004 Jul; 297(2):329-47. PubMed ID: 15212938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matriptase Cleaves EpCAM and TROP2 in Keratinocytes, Destabilizing Both Proteins and Associated Claudins.
    Wu CJ; Lu M; Feng X; Nakato G; Udey MC
    Cells; 2020 Apr; 9(4):. PubMed ID: 32326212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palmitoylation of claudins is required for efficient tight-junction localization.
    Van Itallie CM; Gambling TM; Carson JL; Anderson JM
    J Cell Sci; 2005 Apr; 118(Pt 7):1427-36. PubMed ID: 15769849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpCAM proteolysis and release of complexed claudin-7 repair and maintain the tight junction barrier.
    Higashi T; Saito AC; Fukazawa Y; Furuse M; Higashi AY; Ono M; Chiba H
    J Cell Biol; 2023 Jan; 222(1):. PubMed ID: 36378161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.
    Babina IS; McSherry EA; Donatello S; Hill AD; Hopkins AM
    Breast Cancer Res; 2014 Feb; 16(1):R19. PubMed ID: 24512624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional consequences of EpCam mutation in mice and men.
    Mueller JL; McGeough MD; Peña CA; Sivagnanam M
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G278-88. PubMed ID: 24337010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palmitoylation of Claudin-5 Proteins Influences Their Lipid Domain Affinity and Tight Junction Assembly at the Blood-Brain Barrier Interface.
    Rajagopal N; Irudayanathan FJ; Nangia S
    J Phys Chem B; 2019 Feb; 123(5):983-993. PubMed ID: 30629442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.